ONO PHARMACEUTICAL CO financial statements, including revenue, expenses, profit, and loss

The total revenue of 4528/N for the last quarter is 12.35 B MXN, and it's 21.81% lower compared to the previous quarter. The net income of Q4 23 is 1.91 B MXN.